Breathe Well Live Well
|
Asthma Therapeutics in Asia-Pacific Markets Key Trends, Size, Growth, Shares And Forecast Research Report 2021
Medgadget.com (blog) Researchmoz added Most up-to-date research on “Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns” to its huge collection of research reports. |
View full post on asthma – Google News
WQOW TV News 18 |
2 girls suspended after one shares inhaler during asthma attack
WQOW TV News 18 GARLAND, TX (WKOW) — Two girls who were suspended for sharing an inhaler when one of them was having an asthma attack should be back in their regular classrooms Tuesday, but those suspensions will be on their permanent record. Alexis Kyle and … |
View full post on asthma – Google News
WKOW |
2 girls suspended after one shares inhaler during asthma attack
WKOW GARLAND, TX (WKOW) — Two girls who were suspended for sharing an inhaler when one of them was having an asthma attack should be back in their regular classrooms Tuesday, but those suspensions will be on their permanent record. Alexis Kyle and … |
View full post on asthma – Google News
RT |
Texas 12yo shares inhaler with asthma attack victim, gets 'automatic …
RT Earlier in the week, 12-year-old Indiyah Rush offered her classmate, Alexis Kyle, 13, who has asthma, her inhaler when she saw her wheezing and gasping during gym class at Vernon Schrade Middle School in Dallas. “I was just trying to save her life … Texas Middle Schooler Who Had Asthma Attack Is Punished for Accepting … Girl who has asthma attack reportedly faces punishment for borrowing inhaler Garland ISD girl who suffered asthma attack faces punishment |
View full post on asthma – Google News
|
China Asthma Therapeutics And Pharmacology Market Research Report, Shares …
Medgadget.com (blog) MrrBiz213 “China Asthma Therapeutics Industry 2015 Market Research Report” studies the current scenario as well as future market potential of “Pharmaceutical” globally. The China Asthma Therapeutics Industry 2015 Market Research Report is a … |
View full post on asthma – Google News
|
Health Share's Members Struggle with Obesity, Asthma, ADD, PTSD
The Lund Report What kind of physical and mental health problems top the list among Health Share's 252,000 members? Analysis of 500 hours of analytical data from providers, hospitals and public health organizations is part of Health Share's community health … |
View full post on asthma – Google News
|
Kristin Chenoweth shares asthma story
Tulsa World Kristin Chenoweth will appear on the daytime medical show “The Doctors” Tuesday to speak publicly about her struggles with asthma and the new initiative she has started called “Know Your Count.” “The Doctors” airs at 9 a.m. weekdays on KOKI, channel 23 … |
View full post on asthma – Google News
|
KaloBios shares tank on failed asthma drug trial
San Francisco Business Times (blog) KaloBios (NASDAQ: KBIO), which has seen its stock price tumble since it raised $70 million in an initial public offering a year ago, will discontinue clinical development of the drug, called KB-003, in severe asthma. The monoclonal antibody was safe … KaloBios to Stop KB003 Development for Asthma KaloBios calls it quits on its asthma drug after a Phase II flop KaloBios Pharma pulls plug on asthma drug, shares plunge |
View full post on asthma – Google News
|
KaloBios Shares Slide on Move to Stop Asthma Treatment Study
Wall Street Journal KaloBios Pharmaceuticals Inc.'s (KBIO) shares slumped after the company said it would discontinue development of a treatment for severe asthma, a move that followed disappointing Phase 2 results. Chief Executive Officer David Pritchard said based on … |
View full post on asthma – Google News
|
KaloBios Pharma pulls plug on asthma drug, shares plunge
Reuters (Reuters) – Shares of KaloBios Pharmaceuticals Inc fell nearly 50 percent in extended trade after the company said it would stop developing an asthma drug that failed in a mid-stage study. The drug, KB003, failed to bring about a clinically meaningful … KaloBios stock slides; to stop asthma study KaloBios: KB003 Fails To Meet Primary Goal In Phase 2 Asthma Study |
View full post on asthma – Google News